Randomized phase II dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma

Autor:	Agarwal, N. 1, ∗, Brugarolas, J. 2, 3, Ghatalia, P. 4, George, S. 5, Haanen, J.B. 6, Gurney, H. 7, Ravilla, R. 8, Van der Veldt, A. 9, Beuselinck, B. 10, Pokataev, I. 11, Suelmann, B.B.M. 12, Tuthill, M.H. 13, Vaena, D. 14, Zagouri, F. 15, Wu, J. 16, Perini, R.F. 16, Liu, Y. 16, Merchan, J. 17, Atkins, M.B. 18
Zdroj:	In Annals of Oncology December 2024 35(12):1148-1156
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu